From Krebs to clinic: glutamine metabolism to cancer therapy
By B. Altman, Zachary E. Stine, C. V. Dang. Nature Reviews. Cancer, 2016
823 citations recorded by the source corpus.
Subfields: Biotechnology, Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/de8cb948b9a20cbc2b08aaa3ab33a563e18e60a5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biotechnology
In Cancer Research
In Molecular Biology
Citations in the corpus
- T Cell Dysfunction in Cancer (2018, neutral): “First, glutamine is essential for T cell activation and differentiation, but is also often depleted from the TME due to its use as primary fuel for tumor cells (Altman et al., 2016; Carr et al., 2010).”
- The Acidic Tumor Microenvironment as a Driver of Cancer. (2019, neutral): “A shift toward glutamine metabolism is a characteristic feature of cancer cells (71) and has been demonstrated in cancer cells in response to acidosis lasting 24 h or more (39, 45).”
- Glutamine Metabolism in Cancer: Understanding the Heterogeneity (2017, neutral): “The GLS and GLS2 proteins are highly homologous, and most reports indicate that both are localized to mitochondria [6,93,94].”
- Revisiting the Warburg effect: historical dogma versus current understanding (2020, neutral): “Cancer cells are also addicted to glutamine, mainly driven by the Myc oncogene (Altman et al. 2016).”
- Revisiting the hallmarks of cancer. (2017, positive): “Glutamine is also captured by the mitochondria and converted into glutamate; this may be utilized directly or further converted to α-ketoglutarate (α-KG) that could act as a glucose alternative to produce citrate or share in fatty acid synthesis under unfavorable conditions [145].”
- Understanding the intersections between metabolism and cancer biology (2017, neutral): “A requirement for glutamine metabolism has been observed in many cancer types (Altman et al., 2016), but both tissue of origin and genetics contribute to this phenotype (Yuneva et al., 2012).”
- Targeting Metabolism for Cancer Therapy (2017, neutral): “Glutamine metabolism is upregulated by various oncogenic signaling pathways (Altman et al., 2016).”
- Mitochondrial metabolism and cancer (2017, positive): “This involves not only increased uptake of glucose (a fraction of which is redirected to the pentose phosphate pathway (PPP) for nucleic acid synthesis and glutathione reduction) [70], but also the ability to process glutamine oxidatively (for energy production via the Krebs cycle and the ETC) or re”